-
manufactured and sold in the
United States by
Celgene under the
trade name
Abraxane where it is
designated as an
orphan drug as first-line treatment, in combination...
-
medical researcher, and
transplant surgeon. He is the
inventor of the drug
Abraxane,
which is used for lung, breast, and
pancreatic cancer. Soon-Shiong is...
-
approved protein-bound pa****axel (also
known as nab-pa****axel, sold as
Abraxane) used with gemcitabine. This
regimen may be less toxic—but
perhaps less...
- and non-small-cell lung cancers. Albumin-bound pa****axel (brand name
Abraxane, also
called nab-pa****axel) is an
alternative formulation where pa****axel...
-
Doxorubicin Epirubicin Idarubicin Mitoxantrone Pirarubicin Valrubicin Zorubicin Abraxane Cabazitaxel Docetaxel Larotaxel Pa****axel
Taxotere Tesetaxel Ixabepilone...
-
chemotherapeutic compound,
called nab Technology. From this the
company developed Abraxane, a
treatment for
metastatic breast cancer. In 2010,
Abraxis BioScience...
-
class and the
taxanes class both
include pa****axel (trade
names Taxol,
Abraxane, Onxol, Nov-Onxol) and
docetaxel (trade
names Taxotere, Docecad). "Taxoids:...
- and
transplant surgeon Patrick Soon-Shiong is the
inventor of the drug
Abraxane,
which became known for its
efficacy against lung, breast, and pancreatic...
- the
clinical translation of PNPs. As of 2022, only one PNP
formulation (
Abraxane) and five VLPs (Gardasil, Ceravix, Mosquirix, Sci-B-Vac, Gardasil9) are...
-
acquired Celgene's
operations in
China as well as the
rights to
commercialize Abraxane,
Revlimid and Vidaza, Celgene's
approved drugs in China. As part of the...
